Hu; Yaer

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hu; Yaer.The latest application filed is for "treatment of neurotrophic factor mediated disorders".

Company Profile

0.5.22

Hu; Yaer - Shanghai CN
Hu; Yaer - Shanghai 200025 CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment Of Neurotrophic Factor Mediated Disorders App 20120034193 - Rees; Daryl ; et al.	2012-02-09
Therapeutic Methods And Uses Of Sapogenins And Their Derivatives App 20110190249 - REES; Daryl ; et al.	2011-08-04
Substituted Sapogenins And Their Use App 20100087411 - Barraclough; Paul ; et al.	2010-04-08
5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia Grant 7,507,720 - Barraclough , et al. March 24, 2	2009-03-24
Substituted sapogenins and their use App 20080207576 - Barraclough; Paul ; et al.	2008-08-28
Smilagenin and its use Grant 7,368,137 - Xia , et al. May 6, 2	2008-05-06
Sapogenin derivatives and their use in the treatment of cognitive dysfunction App 20080021004 - Barraclough; Paul ; et al.	2008-01-24
5-Hydroxysapogenin derivatives with anti-dementia activity App 20080020021 - Barraclough; Paul ; et al.	2008-01-24
Smilagenin And Its Use App 20070191290 - Xia; Zongqin ; et al.	2007-08-16
Smilagenin and its use Grant 7,166,308 - Xia , et al. January 23, 2	2007-01-23
5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia App 20060276415 - Barraclough; Paul ; et al.	2006-12-07
5-.beta.-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia Grant 7,138,427 - Barraclough , et al. November 21, 2	2006-11-21
Steroidal sapogenins and their derivatives for treating Alzheimer's disease App 20060182817 - Xia; Zongqin ; et al.	2006-08-17
5-hydroxysapogenin derivatives with anti-dementia activity App 20060165757 - Barraclough; Paul ; et al.	2006-07-27
5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia App 20060100184 - Barraclough; Paul ; et al.	2006-05-11
Therapeutic methods and uses of sapogenins and their derivatives App 20050130948 - Rees, Daryl ; et al.	2005-06-16
Steroidal sapogenins and their derivatives for treating alzheimer's disease Grant 6,812,213 - Xia , et al. November 2, 2	2004-11-02
Sapogenin derivatives, their synthesis and use, and methods based upon their use App 20040147495 - Barraclough, Paul ; et al.	2004-07-29
Smilagenin and its use App 20040081709 - Xia, Zongqin ; et al.	2004-04-29
Substituted sapogenins and their use App 20030158161 - Barraclough, Paul ; et al.	2003-08-21
Smilagenin and anzurogenin-D for the treatment of alzheimer's disease App 20030118673 - Xia, Zongqin ; et al.	2003-06-26
5-hydroxysapogenin derivatives with anti-dementia activity App 20030100542 - Barraclough, Paul ; et al.	2003-05-29
Smilagenin and its use App 20030032604 - Xia, Zongqin ; et al.	2003-02-13
5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia App 20030004147 - Barraclough, Paul ; et al.	2003-01-02
Steroidal sapogenins and their derivatives for treating alzheimer's disease App 20020193317 - Xia, Zongqin ; et al.	2002-12-19
Sapogenin derivatives and their use in the treatment of cognitive dysfunction App 20020183294 - Barraclough, Paul ; et al.	2002-12-05
Smilagenin and its use App 20010043955 - Xia, Zongqin ; et al.	2001-11-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.